Table 2.
Standardized Scores for Psychopathology and Neurocognition
SCZ (n=72) | PMD (n=25) | CON (n=72) | ANOVA F Statistic(df1, df2)a,b | Homogeneity F Statistic | Effect Size (ηp2)c | |
---|---|---|---|---|---|---|
Psychopathology | ||||||
Positive Symptoms | .318 | .082 | −.769 | 81.1 (2,48)***d | 15.6*** | .17/.02 |
Negative Symptoms | .331 | −.081 | −.777 | 55.5(2,47)*** e | 6.6** | .26/.08 |
Disorganized Symptoms | .226 | .230 | −.531 | 7.3(2,107)***d | 2.6 | .12/.00 |
Neurocognition | ||||||
Crystallized IQ | −.467 | .094 | .483 | 23.4(2,166)***f | 0.7 | .22/.08 |
Working Memory | −.510 | −.290 | .399 | 31.0(2,166)***g | 0.8 | .27/.02 |
Episodic Memory | −.625 | −.498 | .756 | 78.8(2,166)***g | 0.6 | .49/.01 |
Executive Functioning | −.484 | −.342 | .401 | 32.3(2, 66)***g | 3.5* | .27/.01 |
p<.05,
p<.01,
p<.001
Note. CON: n=13 for psychopathology and n=72 for neurocognition
Pairwise Comparisons (Bonferroni): p<.05
Welch ANOVA with Tamhane Pairwise Correction for Unequal Variances used when homogeneity non-significant.
First effect size reports difference between all three groups/second effect size reports contrast for SCZ vs. PMD.
SCZ, PMD>CON
SCZ>PMD>CON
SCZ<PMD, CON
SCZ, PMD<CON